A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
Bristol-Myers Squibb
Genmab
Verastem, Inc.
Revolution Medicines, Inc.
Artios Pharma Ltd
Genfleet Therapeutics (Shanghai) Inc.
Servier
Incyte Corporation
Bristol-Myers Squibb
Incyte Corporation
NGM Biopharmaceuticals, Inc
Esperas Pharma Inc.
Cantargia AB
Cantargia AB
Incyte Corporation
National Cancer Institute (NCI)
National Cancer Institute (NCI)